Abstract:Ethnopharmacological relevance The skeletal complications associated with chronic kidney diseases from stages 3–5 in individuals are called Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD), which increases the incidence of cardiovascular diseases drastically and affects the quality of life of patients seriously. Eucommia cortex has the effect of tonifying kidneys and strengthening bones, and salt Eucommia cortex is one of the most commonly used traditional Chinese medicines in the clinical treatment of CKD-MBD instead of Eucommia cortex. However, its mechanism still remains unexplored. Aim of the study The aim of this study was to investigate the effects and mechanisms of salt Eucommia cortex on CKD-MBD by integrating network pharmacology, transcriptomics, and metabolomics. Materials and methods The CKD-MBD mice induced by 5/6 nephrectomy and low calcium/high phosphorus diet were treated with salt Eucommia cortex. The renal functions and bone injuries were evaluated by serum biochemical detection, histopathological analyses, and femur Micro-CT examinations. Differentially expressed genes (DEGs) between the control group and model group, model group and high-dose Eucommia cortex group, model group and high-dose salt Eucommia cortex group were analyzed by transcriptomic analysis. The differentially expressed metabolites (DEMs) between the control group and model group, model group and high-dose Eucommia cortex group, model group and high-dose salt Eucommia cortex group were analyzed by metabolomics analysis.The common targets and pathways were obtained by integrating transcriptomics, metabolomics and network pharmacology, which were identified and verified by in vivo experiments. Results The negative impacts on the renal functions and bone injuries were alleviated with salt Eucommia cortex treatment effectively. Compared with CKD-MBD model mice, the levels of serum BUN, Ca and urine Upr were significantly decreased in the salt Eucommia cortex group. And the Integrated network pharmacology, transcriptomics and metabolomics analysis revealed that Peroxisome Proliferative Activated Receptor, Gamma (PPARG) was the only common target, mainly involved by AMPK signaling pathways. The activation of PPARG in the kidney tissue was significantly decreased in CKD-MBD mice but increased in the salt Eucommia cortex treatment. The AMPK signaling pathway were verified that AMPK expression levels were decreased in CKD-MBD mice but increased in the salt Eucommia cortex treatment. Conclusions Our study presented that salt Eucommia cortex alleviated the negative impact of CKD-MBD on the renal injury and bone injury of mice induced by 5/6 nephrectomy with the low calcium/high phosphorus diet effectively, which is highly likely achieved through the PPARG/AMPK signaling pathway.

Integrated network pharmacology, transcriptomics and metabolomics analysis to reveal the mechanism of salt Eucommia cortex in the treatment of chronic kidney disease mineral bone disorders via the PPARG/AMPK signaling pathway

1H NMR Spectroscopy Analysis of Metabolites in the Kidneys Provides New Insight into Pathophysiological Mechanisms: Applications for Treatment with Cordyceps Sinensis.

Network Pharmacology and Experimental Validation to Reveal the Pharmacological Mechanisms of Chongcaoyishen Decoction Against Chronic Kidney Disease

Integrated metallomic and metabolomic profiling of plasma and tissues provides deep insights into the protective effect of raw and salt-processed Achyranthes bidentata Blume extract in ovariectomia rats

Ophiocordyceps lanpingensis polysaccharides alleviate chronic kidney disease through MAPK/NF-κB pathway

Exploring the Pharmacological Mechanism of Fermented Eucommia Ulmoides Leaf Extract in the Treatment of Cisplatin-Induced Kidney Injury in Mice: Integrated Traditional Pharmacology, Metabolomics and Network Pharmacology

Integrated network analysis and experimental verification of the mechanisms employed by Compound Jixuecao Decoction to improve endoplasmic reticulum stress and apoptosis in chronic renal failure

Cordyceps Sinensis Protects Against Liver and Heart Injuries in a Rat Model of Chronic Kidney Disease: a Metabolomic Analysis

Biomarker identification and pathway analysis of Astragalus membranaceus and Curcuma zedoaria couplet medicines on adenine-induced chronic kidney disease in rats based on metabolomics

Eucommia ulmoides Oliver polysaccharide alleviates glucocorticoid-induced osteoporosis by stimulating bone formation via ERK/BMP-2/SMAD signaling

Altered metabolic profiles and targets relevant to the protective effect of acteoside on diabetic nephropathy in db/db mice based on metabolomics and network pharmacology studies

Protective Effects and Metabolic Regulatory Mechanisms of Shenyan Fangshuai Recipe on Chronic Kidney Disease in Rats

Integrative metabolomic and network pharmacological analysis reveals potential mechanisms of Cardamine circaeoides Hook.f. & Thomson in alleviating potassium oxonate-induced asymptomatic hyperuricemia in rats

Effects of <i>Eucommia ulmoides</i> extract against renal injury caused by long-term high purine diets in rats

Eucommiae cortex extract alleviates renal fibrosis in CKD mice induced by adenine through the TGF-β1/Smad signaling pathway

Fucoidan Ameliorates Renal Injury-Related Calcium-Phosphorus Metabolic Disorder and Bone Abnormality in the CKD–MBD Model Rats by Targeting FGF23-Klotho Signaling Axis

Integrated gut microbiota and fecal metabolomics reveal the renoprotective effect of Rehmanniae Radix Preparata and Corni Fructus on adenine-induced CKD rats

Eucommia, Cuscuta, and Drynaria Extracts Ameliorate Glucocorticoid-Induced Osteoporosis by Inhibiting Osteoclastogenesis Through PI3K/Akt Pathway

Integrative phosphatidylcholine metabolism through phospholipase A 2 in rats with chronic kidney disease

Urinary Metabonomic Study of the Surface Layer of Poria Cocos As an Effective Treatment for Chronic Renal Injury in Rats.

Data Mining and Network Pharmacology Analysis of Kidney-Tonifying Herbs on the Treatment of Renal Osteodystrophy Based on the Theory of "Kidney Governing Bones" in Traditional Chinese Medicine